Financials
| Annual Report & Financial Statements - 31 Dec 2024 | Apr. 30, 2025 |
| Interim Results to 30 June 2024 | Sep. 27, 2024 |
| Annual Report & Financial Statements - 31 Dec 2023 | Apr. 26, 2024 |
| Annual Report & Financial Statements - 31 Dec 2023 | Apr. 26, 2024 |
| Interim Results to 30 June 2023 | Sep. 27, 2023 |
| Annual Report & Financial Statements - 31 Dec 2022 | Jun. 05, 2023 |
| Interim Results to 30 June 2022 | Sep. 23, 2022 |
Proxies
| Notice of Annual General Meeting | Jun. 02, 2025 |
| Results of AGM | Jun. 27, 2024 |
| Notice of Annual General Meeting | Jun. 04, 2024 |
| Results of AGM | Jun. 29, 2023 |
| AGM Statement | Jun. 29, 2023 |
| Notice of Annual General Meeting | Jun. 06, 2023 |
| Result of AGM | Jun. 30, 2022 |
Ownership Update
| Director/PDMR Shareholding | Feb. 04, 2025 |
| Director Share Distribution | Dec. 04, 2024 |
| Director/PDMR Shareholding | Jul. 12, 2023 |
| Director/PDMR Shareholding | Jun. 26, 2023 |
| Director/PDMR Shareholding | Jun. 26, 2023 |
| Director/PDMR Shareholding | Jun. 26, 2023 |
| Holding(s) in Company | Jan. 18, 2023 |
Announcements
| Issue of Equity | Jun. 13, 2025 |
| Extension of Convertible Loan Notes | May. 23, 2025 |
| Corporate Update | May. 13, 2025 |
| Private Placing and Conversion of CLNs | Mar. 14, 2025 |
| Board Changes | Mar. 10, 2025 |
| Proposed Sale of Oncogeni Ltd | Mar. 10, 2025 |
| Update on Sale of Lyramid | Mar. 04, 2025 |
Prospectuses
| Issue of Convertible Loan Notes & Board Changes | May. 23, 2024 |
| Roquefort Therapeutics plc - Single prospectus | Sep. 13, 2022 |